ArticlemedRxiv : the preprint server for health sciences2026

CBFB mutations predict endocrine therapy benefit in estrogen receptor-positive breast cancer.

Adar Yaacov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.